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Abstract 
Nitric oxide is postulated to be involved in the pathophysiology of neurological disorders due 
to hypoxia/ anoxia in brain due to increased release of glutamate and activation of 
N-methyl-D-aspartate receptors. Reactive oxygen species have been implicated in patho-
physiology of many neurological disorders and in brain function. To understand their role in 
anoxia (hypobaric hypoxia) and reperfusion (reoxygenation), the nitric oxide synthase, argi-
ninosuccinate synthetase, argininosuccinate lyase, glutamine synthetase and arginase activities 
along with the concentration of nitrate /nitrite, thiobarbituric acid reactive substances and 
total antioxidant status were estimated in cerebral cortex, cerebellum and brain stem of rats 
subjected to anoxia and reperfusion. The results of this study clearly demonstrated the in-
creased production of nitric oxide by increased activity of nitric oxide synthase. The increased 
activities of argininosuccinate synthetase and argininosuccinate lyase suggest the increased 
and effective recycling of citrulline to arginine in anoxia, making nitric oxide production more 
effective and contributing to its toxic effects. The decreased activity of glutamine synthetase 
may favor the prolonged availability of glutamic acid causing excitotoxicity leading to neuronal 
damage in anoxia. The increased formation of thiobarbituric acid reactive substances and 
decreased total antioxidant status indicate the presence of oxidative stress in anoxia and 
reperfusion. The increased arginase and sustained decrease of GS activity in reperfusion group 
likely to be protective. 
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Introduction 
Glutamate is the major excitatory neurotrans-
mitter in the mammalian central nervous system 
(CNS) (1). It has the potential to be involved in the 
pathogenesis of many CNS diseases either due to ex-
cessive release, reduced uptake or alteration of re-
ceptor function (2). Neuronal excitotoxicity usually 
refers to injury and death of neurons arising from 
prolonged exposure to glutamate and associated ex-
cessive influx of ions into the cell. The resulting cal-
cium overload is particularly neurotoxic, leading to 
the activation of enzymes that degrade proteins, 
membranes and nucleic acids (3). Glutamate is re-Int. J. Med. Sci. 2010, 7 
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leased from damaged axons and glia under hypox-
ic/ischemic conditions (4) and glutamate recep-
tor-mediated excitotoxicity has been described as a 
predominant mechanism of hypoxic injury to the de-
veloping cerebral white matter (5-8). In the CNS, the 
conversion of glutamate to glutamine by glutamine 
synthetase (GS; EC 6.3.1.2), that takes place within the 
astrocytes, represents a key mechanism in the regula-
tion of excitatory neurotransmission under normal 
conditions as well as in injured brain (9). Thus GS is 
involved in modulation of the turnover of glutamate 
through the glutamate-glutamine cycle (10). Reactive 
oxygen species (ROS) are free radicals that are normal 
products of oxygen metabolism and are produced in 
excess during the course of ischemia/reperfusion 
through a variety of mechanism. Intracellular ROS are 
capable of inducing damage and, in severe cases, cell 
death through mitochondrial alterations leading to 
the release of cytochrome c (11-12), through activation 
of the JNK pathway (13) or by activation of nuclear 
factor-KB (NF-KB) transcription factors (14). The ability 
to control ROS is thus critical in neurodegenerative 
diseases, because neuronal damage occurs when the 
“oxidant- anti-oxidant” balances are disturbed in fa-
vor of oxidative stress (15). Generation of nitric oxide 
(NO), a versatile molecule in signaling processes and 
unspecific immune defense, is intertwined with syn-
thesis, catabolism and transport of arginine which 
thus ultimately participates in the regulation of a 
fine-tuned balance between normal and pathophysi-
ological consequences of NO production (16). The 
exact mechanisms contributing to increased produc-
tion of NO in anoxia are not well established. NO in-
duces changes in neuronal, signaling-related func-
tions by several ways (17). NO is synthesized from 
arginine by nitric oxide synthase (NOS; EC 1.14.13.39), 
and the citrulline generated as a by-product can be 
recycled to arginine by successive actions of argini-
nosuccinate synthetase (AS; EC 6.3.4.5) and argini-
nosuccinate lyase (AL; EC 4.3.2.1) via the citrul-
line-NO cycle (18). Arginine in brain is also utilized by 
arginase (EC 3.5.3.1) for production of ornithine. 
Co-induction of AS, cationic amino acid transporter-2, 
and NOS in activated murine microglial cells (19) and 
co-induction of inducible NOS and arginine recycling 
enzymes in cytokine-stimulated PC12 cells and high 
output production of NO were reported (18). In our 
earlier study we reported the increased activities of 
NOS, AS and AL in kainic acid (KA) mediated exci-
totoxicity in rat brain (20). Thus it is hypothesized that 
the citulline-NO cycle enzyme activities are increased 
to facilitate high and continuous production of NO 
and increased NO may decrease the activity of GS and 
increase the oxidative stress in anoxia/reperfusion 
induced excitotoxicity. Global hypobaric hypoxia 
(Anoxia) is associated with many physiological and 
pathological conditions such as pulmonary and car-
diac diseases, high altitude pathophysiology, ob-
structive sleep apnea, depressurization accidents and 
also during incidents involving anesthesia. To under-
stand the role of citrulline-NO cycle enzymes, GS and 
the oxidative status in anoxia and reperfusion, NOS, 
AS, AL, GS and arginase activities along with the 
concentration of NO as nitrate /nitrite (NOx), lipid 
peroxidation products as Thiobarbituric acid reactive 
substances (TBARS) and Total antioxidant status 
(TAS) were estimated in cerebral cortex (CC), cere-
bellum (CB) and brain stem (BS) of rats subjected to 
anoxia (hypobaric hypoxia) and reperfusion (reox-
ygenation). 
Materials and Methods  
Male Sprague Dawley rats weighing 200 – 250 
grams were used for the study. The animals had free 
access to food and water. Animal ethics committee 
and research committee of Universiti Sains Malaysia, 
Health campus, Kubang Kerian, Malaysia, approved 
the experimental design. The animals were divided 
into control, anoxia (global hypobaric hypoxia) and 
reperfusion (reoxygenation) groups (n=6 rats/group). 
In the Anoxia group of animals, anoxia was produced 
as per the procedure of Sadasivudu and Swamy (21). 
This method refers to global hypobaric hypoxia. The 
rats were placed in a desiccator whose outlet was 
connected to a vacuum pump and the air removed 
producing hypobaric conditions. About 4-5 min after 
the exposure of rats to hypobaric condition, the rats 
became lethargic and motionless. At this juncture, the 
rats were removed and killed by decapitation. The 
brains were quickly removed and the different re-
gions (CC, CB and BS) were separated according to 
the procedure described by Sadasivudu and Lajtha 
(22). Each of the brain regions was weighed and used 
for the preparation of homogenates in 0.05M phos-
phate buffer pH 7.3. In the reperfusion group (re- 
oxygenated), the animals were subjected to anoxia as 
described for anoxia group once and after removal of 
animals from desiccator, they were allowed to stay at 
normal conditions and were given normal diet for 5 
days and decapitated and the different brain regions 
(CC, CB and BS) were used for study. It was reported 
by Ananth et al (23) that 5 days showed most severe 
damage in a 1-21 days study after induction of exci-
totoxicity and hence that period (5 days) was chosen 
for the reperfusion group. 
Enzyme assays: Total NOS activity (all isoforms 
of NOS: nNOS, iNOS & eNOS) was estimated by the 
method of Yui et al (24) as described by Swamy et al Int. J. Med. Sci. 2010, 7 
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(25), in which the stable end products, NOx, were 
estimated using the Nitric Oxide Synthase Assay Kit 
from Calbiochem (Catalogue Number 482702). AS, AL 
activities were estimated by the modified method of 
Levin (26) as described by Swamy et al (25). Arginase 
activity was assayed according to the method of 
Herzfeld and Raper (27) as described by Swamy et al 
(24). GS activity was assayed by the method Rowe et 
al (28) as described by Sadasivudu et al (29).  
 Estimations of NO, TBARS and TAS: NO was 
estimated as NOx by Griess reaction after conversion 
of nitrate to nitrite by nitrate reductase, as described 
by Swamy et al (24) using the commercially available 
Nitric Oxide Assay Kit from Cayman Chemical 
Company (Catalogue number 780001; Anna Arbor, 
Machigan, USA). Lipid peroxidation was determined 
by the method of Chatterjee et al (30) by estimating 
TBARS. TAS was estimated according to the method 
of Koracevic et al (31). 
Statistical analysis:  Results were reported as 
mean + standard deviation (SD) from 6 animals for 
each parameter calculated. Statistical analysis of re-
sults was done by one-way analysis of variance 
(ANOVA) followed by post hoc analysis using Bon-
ferroni’s test, using the SPSS software (version 12.0.1) 
to determine the statistical significance of difference in 
values between the control, anoxia and reperfusion 
groups. p value of < 0.05 was taken as statistically 
significant at 95% confidence interval. 
Results 
The activity of NOS (Figure 1) was increased 
significantly in all the three brain regions indicating 
increased production of NO in anoxia. In reperfusion 
group the activities of NOS was increased when 
compared to control, however it was decreased when 
compared to anoxia in all the brain regions tested. In 
anoxia group the increased activity of NOS may 
represent predominantly of nNOS isoform. In reper-
fusion group the activity may be attributed to iNOS 
and nNOS and increased activity may be mainly by 
iNOS due to expected inflammation after anoxia. The 
Figure 2 shows activities of AS, AL and arginase in the 
study. AS and AL activities increased in all the three 
brain regions significantly in anoxia suggesting an 
increased utilization of citrulline for the production of 
arginine in anoxia. In reperfusion group the activities 
of these enzymes were increased when compared to 
control, however they were decreased when com-
pared to anoxia in all the brain regions tested. The 
activity of arginase (Figure 2) showed no significant 
change, indicating there was no increased utilization 
of arginine by this enzyme in anoxia. However in re-
perfusion group arginase activity was significantly 
increased and that may be responsible to curtail the 
supply of arginine for NO production in reperfusion.  
 
 
Figure 1: Activity of NOS in different regions of rat brain in anoxia and reperfusion. Statistical analysis was done by one-way 
ANOVA followed by post hoc analysis using Bonferroni’s test. Values are mean ± S.D. for six animals in each group; 
a p < 
0.001, 
a1 p<0.01 and 
a2 p<0.05 versus control group;
 b p <0.001 versus anoxia group. Int. J. Med. Sci. 2010, 7 
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Figure 2: Activities of AS, AL and Arginase in different regions of rat brain in anoxia and reperfusion. Statistical analysis was 
done by one-way ANOVA followed by post hoc analysis using Bonferroni’s test. Values are mean ± S.D. for six animals in 
each group; 
a p < 0.001, 
a1 p<0.01 and 
a2 p<0.05 versus control group;
 b p <0.001 versus anoxia group. 
 
 
 
The GS activity (Figure 3) was decreased in all 
the tree brain regions in anoxia and showed further 
decrease in reperfusion group compared to control. In 
anoxia the possible decrease of GS may be due to the 
proposed modification of this enzyme by NO (32-33). 
In reperfusion group may be a cumulative effect of 
m a n y  f a c t o r s  s u c h  a s  d o w n  r e g u l a t i o n  o f  e n z y m e  
production and increased clearance along with the 
modulation by NO. 
The figure 4 shows the concentration of NOx, 
TAS and TBARS in this study. The concentration of 
NOx and TBARS increased significantly in all the 
brain regions tested in anoxia compared to control. In 
reperfusion group the concentration of NOx and 
TBARS increased significantly when compared to 
control, however they were decreased when com-
pared to anoxia in all the brain regions tested. The 
pattern observed for the increase in concentration of 
NOx in the three different brain regions was similar to 
that of increased NOS activity in anoxia and reperfu-
sion groups. Concentration of TAS (Figure 4) de-
creased significantly in all the brain regions tested in 
anoxia compared to control. In reperfusion groups the 
decrease of TAS was lesser than that of anoxia group. 
The decrease in TAS and increase in TBARS levels 
confirms that, there is an increased oxidative stress in 
anoxia and reperfusion. 
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Figure 3: Activity of glutamine synthetase in different regions of rat brain in anoxia and reperfusion. Statistical analysis was 
done by one-way ANOVA followed by post hoc analysis using Bonferroni’s test. Values are mean ± S.D. for six animals in 
each group; 
a p < 0.001 versus control group;
 b p <0.001, 
b1 p <0.01 versus anoxia group. 
 
Figure 4: Concentration of NOx
x, TAS
y and TBARS
z in different regions of rat brain in anoxia and reperfusion. 
x Con-
centration expressed as nanomol of NOx /g wet weight of tissue. 
y Concentration expressed as nanomol of uric acid 
equivalent / g wet weight of tissue. 
z Concentration expressed as nanomoles of MDA equivalent / g wet weight of tissue. 
Statistical analysis was done by one-way ANOVA followed by post hoc analysis using Bonferroni’s test. Values are mean ± 
S.D. for six animals in each group; 
a p < 0.001, 
a1 p<0.01 versus control group;
 b p <0.001, 
b1 p<0.01 versus anoxia group. Int. J. Med. Sci. 2010, 7 
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Discussion 
Under physiological conditions, most of the 
glutamate in the CNS localizes to presynaptic vesicles 
(34) and returns there rapidly after being released 
during depolarizing events. However, pathological 
situations such as hypoxia and ischemia can lead to 
excessive release of glutamate and its accumulation in 
the extracellular space, which initiates the pathway of 
neuronal death known as excitotoxicity (35-36). Neu-
ronal excitation involving the excitatory glutamate 
receptors is recognized as an important underlying 
mechanism in neurodegenerative disorders (37). In 
neurons, NO synthesis is stimulated by Ca2+-influx, 
which is induced by activation of glutamate receptors, 
preferentially NMDA receptor (38). The literature 
findings implicate neuronal NO generation in the 
pathogenesis of both direct and secondary excitotoxic 
neuronal injuries in vivo. Excitotoxicity, oxidative 
stress and apoptosis comprise major routs of hypox-
ic-ischemic neuronal death. Each route is likely acti-
vated and propagated through selective transmem-
brane and intracellular signaling system (39). One of 
the events triggered by excessive glutamate release 
and relevant to excitotoxicity is the production of NO 
(40). NO synthesis is activated cerebrovascular dis-
eases by release of glutamate combined with inhibi-
tion of glutamate removal, which leads to NMDA 
receptor over activation and excess Ca2+ influx (41). 
The increased activity of NOS and the increased for-
mation of NO in brain in anoxia as observed by in-
crease in NOx concentration in this study support the 
earlier findings of NO involvement in pathophysiol-
ogy of hypobaric hypoxia in brain (42-43). In this 
study the increased activity of NOS in anoxia may 
represent predominantly the nNOS form. In inflam-
matory conditions microglia and astroglia are capable 
of expressing iNOS (44). Following induction iNOS is 
known to produce large amounts of NO over pro-
longed periods of time, in response to many stimuli 
such as inflammation (45). The activity of NOS in re-
perfusion group may be attributed to iNOS and nNOS 
and the relative contribution to the increased activity 
in reperfusion may be mainly the iNOS form and 
some contribution by nNOS, as reported that nNOS 
expression in degenerating neurons observed through 
increased nNOS immunoreactivity at 5days after in-
duction of excitotoxicity (23). Increased formation of 
NO by stimulated activity of NOS depends upon a 
continuous supply of arginine at the site of synthesis. 
Arginine is a semi essential amino acid and in CNS, its 
availability depends upon: (a) uptake from the circu-
lating arginine and (b) recycling of citrulline to argi-
nine by the actions of AS and AL. L-arginine is 
transported into synaptosomes (46), neurons (47) and 
astroglia (48) by the y+ CAT system. The CAT, a so-
dium-independent transporter, also functions as a 
carrier for L-ornithine in addition to L-arginine (49). 
Activities of AS and AL were elevated in all the brain 
regions of rats subjected to anoxia. The mechanism of 
increased activities of these enzymes is not clear. 
However the possibility of induction cannot be ruled 
out along with the modification of enzyme with un-
known mechanism. Further, our observation of higher 
activities of NOS, AS, and AL in cerebellum suggests 
a higher flux of the citrulline-NO cycle in cerebellum. 
The functional significance of such a high flux of ci-
trulline-NO cycle in cerebellum needs further clarifi-
cation. Our results on the activities of AS and AL 
suggest that the citrulline-NO cycle plays a significant 
role in ensuring adequate supply of arginine for the 
increased production of NO observed in anoxia. A 
similar increase of NOS, AS and AL activities along 
with increased production of NO in KA mediated 
excitotoxicity was earlier reported (20). 
 Apart from NO synthesis L-arginine may also 
serve as a substrate for glutamate formation and may 
also provide increased substrate for arginase (50). No 
significant changes in the activity of arginase in the 
anoxic group indicate that there is no enhanced utili-
zation of arginine by this enzyme in anoxia. However 
the observed increase of arginase in reperfusion 
group may favor decreased production of NO in this 
condition. Both NOS and arginase use arginine as a 
common substrate, and arginase may down-regulate 
NO production by competing with NOS for arginine 
(51), thus may be reducing the effects of NO in re-
perfusion group. The mechanism of increased activity 
of arginase in reperfusion is not known and may be 
up regulated with the supply of oxygen. 
The glutamine synthetase activity is present in 
all parts of brain and it is equally high in cerebral 
cortex, cerebellum and hippocampus (33, 52). Mod-
ulation of GS activity in brain therefore important and 
its impairment or saturation may have pathological 
consequences (53). The decreased activity of GS ob-
served in this study indicates the probable inhibition 
of GS by NO in anoxia. The exact mechanism of inhi-
bition of GS by NO is not known, but it is thought to 
be as a covalent modification as a result of nitrosyla-
tion or nitration of tyrosin in GS (31-32, 54). It is pro-
posed that the inhibition of GS by NO may provide 
prolonged availability of glutamate causing excito-
toxicity in hypobaric hypoxia. Similar decrease of GS 
activity in KA mediated excitotoxicity was reported 
(20). In view of these observations the pharmacologi-Int. J. Med. Sci. 2010, 7 
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cal agents who can increase GS may prove beneficial 
in the treatment of neurological disorders involving 
excitotoxicity as a result of anoxia. The decreased ac-
tivity of GS in reperfusion group compared to anoxia 
may be a cumulative of other factors, including a 
down regulation of GS production and an increased 
clearance of this enzyme apart from modulation of GS 
by NO. Activity of the GS could be involved in the 
regulation of concentration of glutamate in the ex-
tra-cellular space of neurons with other systems, as-
troglial glutamate transporter-I (GLT-1), and also mi-
croglial antiporter for cystine and glutamate which 
may release glutamate when the demand of gluta-
thione synthesis was increased by oxidative stress 
(55). From our study, the increased concentration of 
TBARS and decreased concentration of TAS supports 
the oxidative stress in anoxia.  
In this study the results of citrulline – NO cycle 
enzymes and NOx, TAS and TBARS indicating the 
trend of normalization of these parameters with the 
supply of oxygen in reperfusion group. The increased 
activity of arginase in reperfusion group may be 
beneficial by the way of competing NOS for arginine. 
In a recent study using GS inhibitor, it is showed a 
reduced concentration of glutamine and glutamate in 
brain due to GS inhibition (56). The sustained de-
creased activity of GS in reperfusion group compared 
to anoxia may be a cumulative of other factors, in-
cluding a down regulation of GS production and an 
increased clearance of this enzyme apart from mod-
ulation of GS activity by NO. The prolonged de-
creased GS activity may be providing benefit in re-
ducing glutamine and glutamate concentration be-
cause the glutamine produced in the glial cells enters 
the neuron and converted to glutamate by glutami-
nase, which is described as glutamate – glutamine 
cycle (10, 56). Hence the decreased GS and increased 
arginase activities may be protective in reperfusion 
group. 
 In conclusion, this study clearly demonstrated 
the increased formation of NO and supports the in-
volvement of NO in the pathophysiology of anoxia 
(hypobaric hypoxia) and reperfusion damage in brain. 
The increased activities of AS and AL indicate the 
effective recycling of citrulline to arginine and suggest 
a functional role to citrulline –NO cycle enzymes in 
anoxia. The decreased activity of GS in the brain re-
gions indicate the modulation of its activity by NO 
and favors the prolonged availability of glutamic acid 
causing excitotoxicity leading to neuronal damage in 
anoxia. The increased concentration of TBARS and 
decreased concentration of TAS supports the oxida-
tive stress in anoxia and reperfusion and suggests a 
possible role for anti oxidants in preventing neuro-
degeneration in anoxia and reperfusion injuries to 
brain. The increased arginase and sustained decrease 
of GS activity in reperfusion group are likely to be 
protective. 
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